Strata Critical Medical, Inc. (SRTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Strata Critical Medical, Inc. (SRTA) has a cash flow conversion efficiency ratio of 0.012x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.56 Million) by net assets ($285.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Strata Critical Medical, Inc. net asset quality index to measure how much of total assets are equity-financed.
Strata Critical Medical, Inc. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Strata Critical Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Strata Critical Medical, Inc. (SRTA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Strata Critical Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Strata Critical Medical, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Delek Automotive Systems Ltd
TA:DLEA
|
0.164x |
|
Wilson Bayly Holmes Ovcon Ltd
JSE:WBO
|
0.150x |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
0.053x |
|
Medistim ASA
OL:MEDI
|
0.098x |
|
GHCL Limited
NSE:GHCL
|
0.091x |
|
Heidelberger Druckmaschinen Aktiengesellschaft
F:HDD
|
-0.009x |
|
Phat Dat Real Estate Development Corp
VN:PDR
|
-0.055x |
|
UPC Technology Corp
TW:1313
|
-0.018x |
Annual Cash Flow Conversion Efficiency for Strata Critical Medical, Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Strata Critical Medical, Inc. from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Strata Critical Medical, Inc. (SRTA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $279.07 Million | $-48.91 Million | -0.175x | -1444.26% |
| 2024-12-31 | $221.94 Million | $-2.52 Million | -0.011x | +91.78% |
| 2023-12-31 | $234.30 Million | $-32.35 Million | -0.138x | -2.07% |
| 2022-12-31 | $274.49 Million | $-37.13 Million | -0.135x | -152.41% |
| 2021-12-31 | $291.37 Million | $-15.62 Million | -0.054x | +94.51% |
| 2020-12-31 | $11.08 Million | $-10.82 Million | -0.976x | +52.61% |
| 2019-12-31 | $5.00 Million | $-10.30 Million | -2.060x | -- |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including … Read more